It's the Season 1 Finale! Rather than giving you the usual conversation, Chelsey's bringing back some old friends! She reached out to this year’s guests and asked them to send a quick update on their conditions, treatments, and lives. As we all know by now, chronic conditions are always surprising us and keeping us on our toes, so even the guests that were on more recently have got updates for us.

In Part 2 of Ehlers-Danlos Syndrome with Mom and Vanessa, Vanessa gives Chelsey's mom more information about EDS. Then, her and Chelsey try to come up with a game plan for getting her mom some help.

If you haven’t listened to Part 1 yet, we highly recommend going back and listening to that first.

Vanessa was recently diagnosed with Ehlers-Danlos Syndrome. When she heard Chelsey's mom describing her symptoms on the podcast, she related with almost all of them. She contacted Chelsey and asked if they could chat. She wanted to pass on some advice and support to Chelsey and her mom.

(This is Part 1 of 2)

After being diagnosed with MS, Elizabeth knew it was time to take a good look at her diet.

David was diagnosed with rheumatoid arthritis earlier this year but recently, his condition took a turn and now he's ready to share his story.

Ruth has an array of different conditions, spanning from autoimmune diseases to mental illness with a slew of chronic conditions in between.

More RA talk this week! Ray has tried an array of different RA meds, some have worked better than others, some came with really strange side effects. With all the trial and error he’s done, he’s found what works for him and has some tips for you!

As a belly dancer in her twenties, Dimitra was diagnosed with both fibromyalgia, and thyroid cancer.

Though Lys and Chelsey both have the same condition, they found that our experiences with rheumatoid arthritis have been quite different.

After having a life threatening experience with Sepsis, Laura thought things would get back to normal, but as she found out, post sepsis comes with it’s own complications.